Pembrolizumab in Pediatric Patients with Relapsed or Refractory Classical Hodgkin Lymphoma in Keynote-051: Response by 2007 Revised Response Criteria for Lymphoma and 2014 Lugano Classification
PEDIATRIC BLOOD & CANCER（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要